The research-based pharmaceutical industry is squeezed between an external threat and an internal weakness:
- The threat: healthcare systems make it increasingly difficult to secure reimbursement and patient access for new pharmaceuticals at a viable price.
- The weakness: the industry’s overall R&D productivity is, despite a very dynamic biotech industry, insufficient to fill the pipelines with truly innovative compounds with blockbuster potential.
In other words: an increasing pressure from the market but insufficient R&D productivity to compensate for that. And as long as the generics industry, itself getting increasingly competent and powerful, will continue to erode most revenues and profits from drugs beyond their patent protected life, that pressure will remain, if not further increase.
Hence the increasing pressure on executives in the commercial positions of the pharmaceutical industry to:
- Optimize market access for new brands
- Get the best prices
- Select the best lifecycle management strategies
- Design marketing mix plans that optimally leverage sales opportunities in the market
- Integrate digital into the marketing mix
- Produce better forecasts
- Close better business development and licensing deals
- Gain better insight into stakeholders
- Etc.
Hence the success of C.E.L.forpharma's courses, because our experts equip today’s pharma managers with the competencies they require to better cope with these challenges.
C.E.L.forpharma’s courses are designed and delivered by true experts, i.e. not by professional trainers (with only one exception, to be correct).
Our experts-trainers are most often international consultants who work on complex assignments for the global headquarters of pharmaceutical companies. Some are managing their own niche consultancy, others are senior consultants within a large professional services organization focused on the pharmaceutical and biotech industries. Some have one leg in the academic world – one is even a Full Professor - others have published books, and some regularly speak or chair sessions at leading conferences. In the case of one particular course, the two expert-trainers are executives from pharma companies.
In sum, our experts-trainers are :
- Highly respected specialists with a strong theoretical backbone and a wealth of practically relevant experience in working with pharma & biotech companies
- Consultants and advisors who have worked on many complex assignments across a wide spectrum of therapeutic and geographical markets; but also:
- Carefully selected for their training skills, which is not a given for all experts!
Several C.E.L.forpharma courses address the new training needs of today’s pharma marketers in the pharmaceuticals industry, particularly the product / brand managers.
These courses equip marketing executives with new knowledge & skills in areas of expertise they need to know more about in order to:
- Better contribute to internal meetings on all issues affecting their brands
- Know how to use or incorporate this new knowledge into their brand plans
As our courses have been designed and are delivered by the same experts who also work with the specialists within the industry, C.E.L.forpharma offers a suite of innovative and best-in-class training for pharmaceutical marketers:
- The Pharma Market Access Course – course by Lloyd Morgan & Konrad Wallerstein (bios)
- Health Economics for Non-Health-Economists – course by Lieven Annemans (bio)
- The Pharma Pricing Course for Pricing & Marketing Executives – course by Gary Johnson (bio)
- The Pharma Forecasting Course – course by Gary Johnson (bio)
- The Digital Pharma Marketing Course – course by Fonny Schenck (bio)
- Optimizing Brand Lifecycle Management Strategies - course by Neal Hansen (bio)
While the pharmaceuticals marketing courses listed above address the hot issues, C.E.L.forpharma also offers business education for pharmaceutical product managers to learn how to design marketing mix plans that optimally leverage sales opportunities in the market:
- The Pharma Brand Planning Course – course by Edouard Demeire (bio)
The Pharma Brand Planning Course includes a module on how to make your competition irrelevant by creating a Blue Ocean market environment for your brand, which basically drills down to delivering value innovation.
The biotech industry is a critical source for new compounds in R&D. Hence the strategic importance of the business development function in both the pharmaceutical and biotech industries.
Business development (BD) has become more and more systematised over the last decade or so, particularly in large companies where the three pillars of Search & Evaluation, Negotiation and Alliance Management have taken root. Each function is staffed independently to different levels of specialism depending on the individual company’s design.
Smaller pharma companies however, including the biotech companies, cannot allocate so many resources to BD, meaning that one or two people must cover the whole range of activities needed to achieve successful transactions.
Whether you are part of a large BD department within big pharma, or a senior executive within a biotech or small pharma company responsible for all BD activities (often in addition to other roles!), we offer an excellent overview course covering the whole BD process:
- The Pharma Business Development Course – course by Martin Austin (bio)
Anyone very specifically looking for an out-licensing course or a course on how to calculate the value of compounds in development and biotech companies, we can highly recommend:
- The Pharmaceutical Out-licensing Course - course by David Scott (bio)
- The Pharma-Biotech Product & Company Valuation Course – course by P. Frei & J. Ohlsson (bios)
Not surprisingly, the latter also attracts biotech CEOs and executives from the investment community and tech transfer organizations.
Obviously, many experienced BD executives will benefit from our courses that relate to pre-launch marketing issues:
- The Pharma Market Access Course – course by Lloyd Morgan & Konrad Wallerstein (bios)
- Health Economics for Non-Health-Economists – course by Lieven Annemans (bio)
- The Pharma Pricing Course for Pricing & Marketing Executives – course by Gary Johnson (bio)
- The Pharma Forecasting Course – course by Gary Johnson (bio)
Since its start in 2005 C.E.L.forpharma has attracted a surprisingly international audience at each of its training classes. Typically, in our classes averaging between 8 and maximum 20 participants, there would be at least 6 different nationalities.
Such is the uniqueness and quality of our short-duration courses for the pharmaceutical and biotech industries, that our delegates include executives not only from all over Europe but also from beyond: Middle & Far East, Russia, Turkiye, U.S.A. ... .
Thus, when you decide to attend one of our short-duration courses for pharmaceutical and biotech executives, you will additionally benefit from:
- Interacting with your peers from other geographical markets
- Learning about small local companies and biotech companies you may never have heard of before but who partner with global pharma players
- Better understanding the role of other healthcare industry sectors (e.g. drug delivery)
Click here for further details about the composition of our executive audiences.
Upon completion of each course we ask our participants to complete an evaluation form, at the end of which we invite them to write a testimonial. In 2009, we received numerous new written testimonials at the end of each course, without having to push for it! Not surprisingly, the quality ratings and written feedback from most participants read positive to very positive across all our courses.
We invite you to read the testimonials. They are the word-of-mouth for our courses in written format. They are all authentic!
- Testimonials for The Pharma Market Access Course
- Testimonials for The Pharma Pricing Course for Pricing & Marketing Executives
- Testimonials for The Pharma Forecasting Course
- Testimonials for Optimizing Brand Lifecycle Management Strategies
- Testimonials for The Pharma Business Development Course
- Testimonials for The Pharma-Biotech Product & Company Valuation Course
- Testimonials for The Pharma Brand Planning Course
- Testimonials for Health Economics for Non-Health-Economists
- Testimonials for The Digital Pharma Marketing Course